Receiver Operating Characteristic Curve Analysis of SEER Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) Outcome Data: Identification and Optimization of Predictive Models

  • Cheung, Min Rex (New York City Cyberknife Center)
  • Published : 2014.08.30


Purpose: This study used receiver operating characteristic curves to analyze Surveillance, Epidemiology and End Results (SEER) medulloblastoma (MB) and primitive neuroectodermal tumor (PNET) outcome data. The aim of this study was to identify and optimize predictive outcome models. Materials and Methods: Patients diagnosed from 1973 to 2009 were selected for analysis of socio-economic, staging and treatment factors available in the SEER database for MB and PNET. For the risk modeling, each factor was fitted by a generalized linear model to predict the outcome (brain cancer specific death, yes/no). The area under the receiver operating characteristic curve (ROC) was computed. Similar strata were combined to construct the most parsimonious models. A Monte Carlo algorithm was used to estimate the modeling errors. Results: There were 3,702 patients included in this study. The mean follow up time (S.D.) was 73.7 (86.2) months. Some 40% of the patients were female and the mean (S.D.) age was 16.5 (16.6) years. There were more adult MB/PNET patients listed from SEER data than pediatric and young adult patients. Only 12% of patients were staged. The SEER staging has the highest ROC (S.D.) area of 0.55 (0.05) among the factors tested. We simplified the 3-layered risk levels (local, regional, distant) to a simpler non-metastatic (I and II) versus metastatic (III) model. The ROC area (S.D.) of the 2-tiered model was 0.57 (0.04). Conclusions: ROC analysis optimized the most predictive SEER staging model. The high under staging rate may have prevented patients from selecting definitive radiotherapy after surgery.




  1. Barnholtz-Sloan JS, Severson RK, Stanton B, Hamre M, Sloan AE (2005). Pediatric brain tumors in non-Hispanics, Hispanics, African Americans and Asians: differences in survival after diagnosis. Cancer Causes Control, 16, 587-92.
  2. Bishop AJ, McDonald MW, Chang AL, Esiashvili N (2012). Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology and End Results (SEER) Data. Int J Radiat Oncol Biol Phys, 82, 341-7.
  3. Cheung MR (2013a). African American race and low income neighborhoods decrease cause specific survival of endometrial cancer: a SEER analysis. Asian Pac J Cancer Prev, 14, 2567-70.
  4. Cheung MR (2013b). Low income and rural county of residence increase mortality from bone and joint sarcomas. Asian Pac J Cancer Prev, 14, 5043-7.
  5. Cheung MR (2013c). Using SEER data to quantify effects of low income neighborhoods on cause specific survival of skin melanoma. Asian Pac J Cancer Prev, 14, 3219-21.
  6. Cheung R (2012). Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: a US SEER data analysis. Asian Pac J Cancer Prev, 13, 4587-91.
  7. Cheung R. (2013). Racial and social economic factors impact on the cause specific survival of pancreatic cancer: a SEER survey. Asian Pac J Cancer Prev, 14, 159-63.
  8. Cheung R, Altschuler MD, D'Amico AV, et al (2001a). ROCoptimization may improve risk stratification of prostate cancer patients. Urology, 57, 286-90.
  9. Cheung R, Altschuler MD, D'Amico AV, et al (2001b). Using the receiver operator characteristic curve to select pretreatment and pathologic predictors for early and late post-prostatectomy PSA failure. Urology, 58, 400-5.
  10. Curran EK, Le GM, Sainani KL, Propp JM, Fisher PG (2009). Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. J Neurooncol, 95, 81-5.
  11. D'Amico AV, Desjardin A, Chung A, et al (1998). Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer, 82, 1887-96.<1887::AID-CNCR11>3.0.CO;2-P
  12. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006). Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus, 20, 1.
  13. Downing S, Ahuja N, Oyetunji TA, Chang D, Frederick WA (2010). Disparity in limb-salvage surgery among sarcoma patients. Am J Surg, 199, 549-53.
  14. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F (2002). Childhood cancer survival in Europe and the United States. Cancer, 95, 1767-72.
  15. Gross CP, Smith BD, Wolf E, Andersen M (2008). Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer, 112, 900-8.
  16. Halperin EC, Miranda ML, Watson DM, George SL, Stanberry M (2004). Medulloblastoma and birth date: evaluation of 3 U.S. datasets. Arch Environ Health, 59, 26-30.
  17. Hanley JA and McNeil BJ. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29-36.
  18. Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B (1995). Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. JCO, 13, 93-100.
  19. Lai R (2008). Survival of patients with adult medulloblastoma: a population-based study. Cancer, 112, 1568-74.
  20. Lund MJ, Brawley OP, Ward KC, et al (2008). Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat, 109, 545-57.
  21. Martinez SR, Beal SH, Chen SL, et al (2010). Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys, 78, 787-92.
  22. Martinez SR, Tseng WH, Canter RJ, et al (2012). Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer, 118, 196-204.
  23. Packer RJ, Macdonald T, Vezina G, Keating R, Santi M (2012). Medulloblastoma and primitive neuroectodermal tumors. Handb Clin Neurol, 105, 529-48.
  24. Schlichting JA, Soliman AS, Schairer C, et al (2012). Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. Cancer Epidemiol Biomarkers Prev, 21, 155-65.
  25. Shavers VL, Harlan LC, Stevens JL (2003). Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer, 97, 134-47.
  26. Smee RI, Williams JR, De-Loyde KJ, Meagher NS, Cohn R (2012). Medulloblastoma: progress over time. J Med Imaging Radiat Oncol, 56, 227-34.
  27. Smoll NR (2012). Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs). Cancer, 118, 1313-22.
  28. von Hoff K and Rutkowski S (2012). Medulloblastoma. Curr Treat Options Neurol, 14, 416-26.
  29. Wampler NS, Lash TL, Silliman RA, Heeren TC (2005). Breast cancer survival of American Indian/Alaska Native women, 1973-1996. Soz Praventivmed, 50, 230-7.
  30. Yao N, Lengerich EJ, Hillemeier MM (2012). Breast cancer mortality in Appalachia: reversing patterns of disparity over time. J Health Care Poor Underserved, 23, 715-25.

Cited by

  1. Analysis of SEER Adenosquamous Carcinoma Data to Identify Cause Specific Survival Predictors and Socioeconomic Disparities vol.17, pp.1, 2016,